Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial.
López-Medina E, López P, Hurtado IC, Dávalos DM, Ramirez O, Martínez E, Díazgranados JA, Oñate JM, Chavarriaga H, Herrera S, Parra B, Libreros G, Jaramillo R, Avendaño AC, Toro DF, Torres M, Lesmes MC, Rios CA, Caicedo I.
López-Medina E, et al.
JAMA. 2021 Apr 13;325(14):1426-1435. doi: 10.1001/jama.2021.3071.
JAMA. 2021.
PMID: 33662102
Free PMC article.
Clinical Trial.
By day 21, 82% in the ivermectin group and 79% in the placebo group had resolved symptoms. ...The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand the effects of ivermectin on oth …
By day 21, 82% in the ivermectin group and 79% in the placebo group had resolved symptoms. ...The findings do not support the use of …